Advertisement

Topics

Latest "Biomarker discovery Driving technologies" News Stories

00:55 EST 24th February 2017 | BioPortfolio

Here are the most relevant search results for "Biomarker discovery Driving technologies" found in our extensive news archives from over 250 global news sources.

More Information about Biomarker discovery Driving technologies on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Biomarker discovery Driving technologies for you to read. Along with our medical data and news we also list Biomarker discovery Driving technologies Clinical Trials, which are updated daily. BioPortfolio also has a large database of Biomarker discovery Driving technologies Companies for you to search.

Showing "Biomarker discovery Driving technologies" News Articles 1–25 of 17,000+

Relevant

Biomarkers technologies,markets and companies Prices from USD $5000

SummaryThis report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological responses to a therapeutic intervention. Tests based on biomarkers have been around for more than half a century, but interest in their application for diagnostics and drug discovery...


Stemina Biomarker Discovery, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350

SummaryMarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.MarketLines' Stemina Biomarker Discovery, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, det...

Agilent Technologies, Transcriptic collaborate to automate discovery biology

Agilent Technologies and Transcriptic have agreed to partner their technologies to provide a solution for convenient, broad scale synthetic and discovery biology research. Agilent continues its strong program of fostering innovation using the Agilent portfolio by collaborating with rising companies such as Transcriptic to develop novel synthetic biology solutions. Transcriptic’s automated discov...


Celebration to Commemorate Ocean Ridge Biosciences’ Re-Opening at New Facility

FOR IMMEDIATE RELEASE Celebration to Commemorate Ocean Ridge Biosciences’ Re-Opening at New Facility Expanded and upgraded facility enables growth of South Florida life sciences-based company DEERFIELD BEACH, FL, October 25th, 2016 - Ocean Ridge Biosciences (ORB), a leader in RNA profiling and biomarker discovery services, will celebrate a grand re-opening at its new location, 394 SW 12th Aven...

Carmentix and the University of Melbourne announce “Preterm Birth Biomarker Discovery” initiative

This collaborative clinical study aims to validate novel biomarkers discovered by Carmentix. The post Carmentix and the University of Melbourne announce “Preterm Birth Biomarker Discovery” initiative appeared first on PharmaAsia.

#jobs #lifescience Immunocore: Bioinformatician- Biomarker discovery – Milton Park, Oxfordshire

// Competitive salary: Immunocore: Immunocore Limited, just south of Oxford, UK, is an innovative and dynamic biotechnology… Milton Park, Oxfordshire from Job Search RSS http://ift.tt/2eo9hRK Cet article #jobs #lifescience Immunocore: Bioinformatician- Biomarker discovery – Milton Park, Oxfordshire est apparu en premier sur Biotech 365.

Agilent Technologies and Transcriptic Collaborate to Automate Discovery Biology

Agilent Technologies Inc. and Transcriptic Inc. have agreed to partner their technologies to provide a solution for convenient, broad scale synthetic and discovery biology research. Agilent continues its strong program of fostering innovation using the Agilent portfolio by collaborating with rising ...

Global Cancer Biomarkers Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 2022 Prices from USD $3900

The global cancer biomarkers market is anticipated to reach around $17 billion by 2022, with an estimated CAGR of 12.6% from 2016 to 2022. The market growth is driven by factors such as increasing prevalence of cancer, various technological developments in omics technologies; increased demand for personalized medicines especially in cancer therapies, rising number of clinical trials in developed a...

Global Cancer Biomarkers Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 2022 Prices from USD $5900

The global cancer biomarkers market is anticipated to reach around $17 billion by 2022, with an estimated CAGR of 12.6% from 2016 to 2022. The market growth is driven by factors such as increasing prevalence of cancer, various technological developments in omics technologies; increased demand for personalized medicines especially in cancer therapies, rising number of clinical trials in developed a...

Lantern Pharma, Intuition Systems partner in biomarker discovery

Lantern Pharma has reached an agreement to collaborate with India-based AI and data analytics company, Intuition Systems. Lantern Pharma is a privately held, global biotech company pioneering the field of precision oncology. Lantern’s proprietary approach to drug development is driven by advanced genomics and machine learning-based artificial intelligence (AI), which when combined, are advancing...

Evotec, Merck sign deals to partner on target discovery technologies

Evotec and Merck have signed agreements to collaborate on target discovery technologies.

New biomarker is higher in suicide attempters and associated with stress response

Researchers at Lund and Malmö universities in Sweden have measured a biomarker in cell-free blood plasma which can be linked to an overactive stress system in suicidal individuals. This biomarker can hopefully be used in future psychiatric studies.

Agilent, Transcriptic Partner on Biologic Discovery Solutions

Will combine technologies to provide a solution for convenient, synthetic and discovery biology research

Japan Safety Biomarker Workshop

(The Critical Path Institute (C-Path)) The Japan Safety Biomarker Workshop, held February 20-21 at the RIKEN Institute, in Yokohama, Japan, assembles leading scientists and researchers from industry and academia, and government regulatory authorities. Attendees will gain perspective on biomarker development and biomarker application in preclinical and clinical research. Topics include an overview ...

Insilico Medicine launches a deep learned biomarker of aging, Aging.AI 2.0 for testing

(InSilico Medicine, Inc.) Insilico Medicine, Inc., a company applying latest advances in deep learning to biomarker development, drug discovery and aging research, launched Aging.AI 2.0. Comparing Aging.AI 1.0 using 41 blood biochemistry biomarkers, Aging.AI 2.0 uses just 33 parameters from the blood test and has slightly higher mean absolute error.

Global Central Nervous System CNS Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 2022 Prices from USD $5900

A biomarker is biological feature that can be used to measure the presence or progress of disease or the effects of treatment. For example, prostate specific antigen PSA is a biomarker for cancer of prostate. Biomarkers enable the researchers to quickly see large number of biological analytics. In the present scenario, the research and development in CNS market has paced up due to support from gov...

Global Central Nervous System CNS Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 2022 Prices from USD $3900

A biomarker is biological feature that can be used to measure the presence or progress of disease or the effects of treatment. For example, prostate specific antigen PSA is a biomarker for cancer of prostate. Biomarkers enable the researchers to quickly see large number of biological analytics. In the present scenario, the research and development in CNS market has paced up due to support from gov...

BRIEF-Evotec, Merck to collaborate on target discovery technologies

* Evotec and Merck enter into agreements to collaborate on target discovery technologies Source text for Eikon: Further company coverage:

Evotec, Merck to collaborate on target discovery technologies

Evotec has announced the signing of a set of collaboration agreements with the life science business of Merck, which will combine Merck’s portfolio of genome editing technologies with Evotec’s versatile screening platforms and disease expertise. Evotec will leverage Merck’s comprehensive collection of genetic reagents such as viral CRISPR and shRNA libraries to enable new target ...

e-Therapeutics (ETX) - Focused on value creation

Edison Investment Research - Pharmaceutical & healthcare - e-Therapeutics: e-Therapeutics (ETX) is focused on driving value in its discovery platform. Costs will be reduced as the 17 product candidates in discovery as of July 2016 have been cut to a core five. Cash of £19.9m and future tax credits of c £6m, along with a reduction in cash burn, should fund ETX through to 2019. Legacy asse...

FNIH releases final biomarker framework

The Foundation for the National Institutes of Health (FNIH) released its framework outlining basic evidence required for biomarker qualification. The framework is designed to provide predictable and specific regulatory criteria, and was produced through collaboration among FNIH, FDA, NIH, the

HFSA: Can a Biomarker Explain the PARADIGM Findings? (CME/CE)

(MedPage Today) -- A biomarker 1,000 pound gorilla

Bridging the advances in AI and quantum computing for drug discovery and longevity research

(InSilico Medicine, Inc.) Insilico Medicine Inc. and YMK Photonics Inc. announced a research collaboration and business cooperation to develop photonics quantum computing and accelerated deep learning techniques for drug discovery, biomarker development and aging research.

Insilico Medicine to present on Deep Learning Pipelines for Drug Discovery at GTC DC

(InSilico Medicine, Inc.) Insilico Medicine Inc. will present its most recent advances in applying the deep learning techniques to biomarker development and drug discovery at the GPU Technology Conference Washington, D.C.

Precision Oncology Company Lantern Pharma Enters Collaborative Service Agreement With Artificial Intelligence And Data Analytics Leader Intuition Systems To Aid In Biomarker Discovery

  Life Sciences Jobs   ...


Quick Search
Advertisement
 

News Quicklinks